Notify me when Benjamin J. Zeskind files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| IMRX | Immuneering Corporation | Class A common stock, par value $0.001 per share | 12.8% | $5.77M | 3.98M | BENJAMIN J. ZESKIND | 31 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|